Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05195164 · ClinicalTrials.gov registry record
The Effects of Orchiectomy and Age on Vascular and Metabolic Health in Older Versus Younger Transgender Women
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 17
- Enrollment target
NCT05195164: Completed study, sponsored by University of Colorado, Denver.
NCT05195164 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05195164 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
This study plans to learn more about differences in heart disease risk after gender-affirming orchiectomy (i.e., testes removal) in older transgender (trans) women compared to younger trans women.
Primary Outcome
Brachial artery flow-mediated dilation (FMD), as measured by ultrasound.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2021-03-22 |
| Est. Completion | 2023-12-31 |
What the finished NCT05195164 record still lists
NCT05195164 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT05195164 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05195164 about?
NCT05195164 is a clinical study titled "The Effects of Orchiectomy and Age on Vascular and Metabolic Health in Older Versus Younger Transgender Women". This study plans to learn more about differences in heart disease risk after gender-affirming orchiectomy (i.e., testes removal) in older transgender (trans) women compared to younger trans women.
What is the current status of trial NCT05195164?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2021-03-22. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05195164?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT05195164?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI